Clinical Trial Update: Study of Intrathecal ELP-02 for Charcot-Marie-Tooth Disease Type 4J (CMT4J) [Phase 1, Phase 2]

View source ↗

Summary

This update describes a Phase 1/2 study of intrathecal ELP-02 for Charcot-Marie-Tooth disease Type 4J that is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Charcot-marie-tooth Disease Type 4j

Drugs mentioned

• ELP-02

Snippet

Sponsor: Elpida Therapeutics SPC | Conditions: Charcot-Marie-Tooth Disease Type 4J | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING